drugset / Trial / NCT04666792

PrEParing Family Planning Clinics to Streamline Integration of HIV Prevention Services for Young Women in Kenya

NCT04666792 ↗

NaSingle-groupOpen-labelPrevention

Summary

This a prospective, open-label implementation project to catalyze integration of HIV prevention and PrEP care services for adolescent girls and young women in family planning clinics in Kenya.

Timeline

Start
2021-03-01
Primary completion
2024-12-31
Completion
2024-12-31

Outcome

Met primary endpoint

paper The proportion of woman-encounters screened for PrEP significantly increased from 2.9% (213/7386) to 91.6% (19560/21343) PMID 42232582 ↗

paper Oral PrEP initiation among women assessed to be at elevated HIV risk increased from 3.9% (5/120) to 40.6% (985/2429) PMID 42232582 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Tenofovir disoproxil fumarate Small molecule — Oral
Subject emtricitabine Other / unclassified — Oral